Genetic Historical Balance Sheet

GTG Stock

0.04 0.00 0.00%

Trend analysis of Genetic Technologies balance sheet accounts such as Total Current Liabilities of 2 M or Total Stockholder Equity of 1.6 M provides information on Genetic Technologies' total assets, liabilities, and equity, which is the actual value of Genetic Technologies to its prevalent stockholders. By breaking down trends over time using Genetic Technologies balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Genetic Technologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Genetic Technologies is a good buy for the upcoming year.

Genetic Technologies Inventory

176,530

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genetic Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Genetic Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Genetic Technologies at a specified time, usually calculated after every quarter, six months, or one year. Genetic Technologies Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Genetic Technologies and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Genetic currently owns. An asset can also be divided into two categories, current and non-current.

Genetic Technologies Balance Sheet Chart

At this time, Genetic Technologies' Net Tangible Assets are comparatively stable compared to the past year. Short and Long Term Debt is likely to gain to about 845.6 K in 2025, whereas Total Current Liabilities is likely to drop slightly above 2 M in 2025.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Genetic Technologies assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Genetic Technologies books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Genetic Technologies balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Genetic Technologies are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Genetic Technologies' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Genetic Technologies current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genetic Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	1.3M	1.1M	1.0M	901.4K
Total Assets	14.9M	6.2M	5.6M	5.3M

Other Current Liab Total Assets

Genetic Technologies balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Good Will	Other Current Assets	Short Term Debt
Total Assets		0.17	-0.1	0.98	0.83	-0.9	-0.05	-0.35	0.91	0.21	-0.61	0.91	-0.07	0.21	-0.12	-0.07	-0.31	-0.15	0.33	0.94	0.17	0.21	-0.39	0.01	0.04	-0.44
Other Current Liab	0.17		0.48	0.06	0.53	0.19	0.3	0.31	-0.18	0.81	-0.34	-0.18	0.11	-0.29	0.25	0.23	0.0	0.57	0.31	-0.14	-0.24	0.33	0.49	-0.01	-0.07	-0.16
Total Current Liabilities	-0.1	0.48		-0.26	0.18	0.37	-0.52	0.93	-0.33	0.49	-0.11	-0.33	0.69	0.43	-0.2	-0.19	-0.5	0.88	0.79	-0.26	0.56	0.12	0.29	-0.36	0.18	0.62
Total Stockholder Equity	0.98	0.06	-0.26		0.75	-0.94	0.03	-0.5	0.94	0.12	-0.57	0.94	-0.21	0.16	-0.06	-0.03	-0.22	-0.33	0.19	0.95	0.09	0.17	-0.47	0.09	0.01	-0.53
Property Plant And Equipment Net	0.83	0.53	0.18	0.75		-0.58	-0.04	-0.1	0.59	0.55	-0.66	0.6	0.1	0.12	-0.07	-0.05	-0.35	0.19	0.52	0.64	0.12	0.36	-0.09	-0.07	0.03	-0.35
Net Debt	-0.9	0.19	0.37	-0.94	-0.58		0.12	0.53	-1.0	0.18	0.5	-1.0	0.25	-0.32	0.27	0.22	0.15	0.42	-0.07	-0.98	-0.22	0.08	0.48	0.03	-0.02	0.52
Retained Earnings	-0.05	0.3	-0.52	0.03	-0.04	0.12		-0.52	-0.15	0.23	0.22	-0.15	-0.5	-0.89	0.76	0.71	0.55	-0.38	-0.62	-0.15	-0.92	0.36	0.07	0.6	-0.36	-0.52
Accounts Payable	-0.35	0.31	0.93	-0.5	-0.1	0.53	-0.52		-0.49	0.24	0.15	-0.5	0.75	0.39	-0.22	-0.17	-0.4	0.87	0.63	-0.43	0.52	0.05	0.34	-0.31	0.06	0.72
Cash	0.91	-0.18	-0.33	0.94	0.59	-1.0	-0.15	-0.49		-0.19	-0.5	1.0	-0.21	0.34	-0.31	-0.25	-0.18	-0.35	0.1	0.99	0.25	-0.08	-0.44	-0.06	0.04	-0.5
Non Current Assets Total	0.21	0.81	0.49	0.12	0.55	0.18	0.23	0.24	-0.19		-0.39	-0.19	0.22	-0.28	0.3	0.21	-0.17	0.4	0.43	-0.14	-0.19	0.47	0.18	-0.04	-0.02	0.04
Non Currrent Assets Other	-0.61	-0.34	-0.11	-0.57	-0.66	0.5	0.22	0.15	-0.5	-0.39		-0.51	-0.04	-0.28	0.34	0.41	0.38	-0.09	-0.38	-0.48	-0.26	0.12	-0.1	0.43	-0.01	0.27
Cash And Short Term Investments	0.91	-0.18	-0.33	0.94	0.6	-1.0	-0.15	-0.5	1.0	-0.19	-0.51		-0.21	0.34	-0.31	-0.25	-0.17	-0.35	0.09	0.99	0.25	-0.08	-0.44	-0.07	0.04	-0.5
Net Receivables	-0.07	0.11	0.69	-0.21	0.1	0.25	-0.5	0.75	-0.21	0.22	-0.04	-0.21		0.29	-0.21	-0.18	-0.66	0.61	0.67	-0.12	0.43	0.32	0.08	-0.28	-0.24	0.8
Common Stock Total Equity	0.21	-0.29	0.43	0.16	0.12	-0.32	-0.89	0.39	0.34	-0.28	-0.28	0.34	0.29		-0.78	-0.73	-0.39	0.28	0.5	0.32	0.98	-0.52	-0.1	-0.58	0.3	0.25
Common Stock Shares Outstanding	-0.12	0.25	-0.2	-0.06	-0.07	0.27	0.76	-0.22	-0.31	0.3	0.34	-0.31	-0.21	-0.78		0.98	0.09	-0.24	-0.2	-0.22	-0.71	0.73	-0.14	0.88	-0.23	-0.12
Inventory	-0.07	0.23	-0.19	-0.03	-0.05	0.22	0.71	-0.17	-0.25	0.21	0.41	-0.25	-0.18	-0.73	0.98		0.06	-0.2	-0.15	-0.15	-0.66	0.76	-0.2	0.94	-0.19	-0.13
Other Stockholder Equity	-0.31	0.0	-0.5	-0.22	-0.35	0.15	0.55	-0.4	-0.18	-0.17	0.38	-0.17	-0.66	-0.39	0.09	0.06		-0.37	-0.85	-0.28	-0.53	-0.42	0.15	0.07	-0.15	-0.56
Total Liab	-0.15	0.57	0.88	-0.33	0.19	0.42	-0.38	0.87	-0.35	0.4	-0.09	-0.35	0.61	0.28	-0.24	-0.2	-0.37		0.63	-0.3	0.39	0.06	0.54	-0.4	0.17	0.48
Property Plant And Equipment Gross	0.33	0.31	0.79	0.19	0.52	-0.07	-0.62	0.63	0.1	0.43	-0.38	0.09	0.67	0.5	-0.2	-0.15	-0.85	0.63		0.2	0.64	0.36	-0.09	-0.21	0.29	0.5
Total Current Assets	0.94	-0.14	-0.26	0.95	0.64	-0.98	-0.15	-0.43	0.99	-0.14	-0.48	0.99	-0.12	0.32	-0.22	-0.15	-0.28	-0.3	0.2		0.26	0.06	-0.49	0.02	0.05	-0.43
Common Stock	0.17	-0.24	0.56	0.09	0.12	-0.22	-0.92	0.52	0.25	-0.19	-0.26	0.25	0.43	0.98	-0.71	-0.66	-0.53	0.39	0.64	0.26		-0.38	-0.1	-0.55	0.33	0.41
Property Plant Equipment	0.21	0.33	0.12	0.17	0.36	0.08	0.36	0.05	-0.08	0.47	0.12	-0.08	0.32	-0.52	0.73	0.76	-0.42	0.06	0.36	0.06	-0.38		-0.25	0.65	-0.18	0.18
Short Long Term Debt Total	-0.39	0.49	0.29	-0.47	-0.09	0.48	0.07	0.34	-0.44	0.18	-0.1	-0.44	0.08	-0.1	-0.14	-0.2	0.15	0.54	-0.09	-0.49	-0.1	-0.25		-0.38	-0.06	0.09
Good Will	0.01	-0.01	-0.36	0.09	-0.07	0.03	0.6	-0.31	-0.06	-0.04	0.43	-0.07	-0.28	-0.58	0.88	0.94	0.07	-0.4	-0.21	0.02	-0.55	0.65	-0.38		-0.18	-0.23
Other Current Assets	0.04	-0.07	0.18	0.01	0.03	-0.02	-0.36	0.06	0.04	-0.02	-0.01	0.04	-0.24	0.3	-0.23	-0.19	-0.15	0.17	0.29	0.05	0.33	-0.18	-0.06	-0.18		0.06
Short Term Debt	-0.44	-0.16	0.62	-0.53	-0.35	0.52	-0.52	0.72	-0.5	0.04	0.27	-0.5	0.8	0.25	-0.12	-0.13	-0.56	0.48	0.5	-0.43	0.41	0.18	0.09	-0.23	0.06

Click cells to compare fundamentals

Genetic Technologies Account Relationship Matchups

Genetic Technologies balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	23.0M	20.8M	14.9M	6.2M	5.6M	5.3M
Other Current Liab	955.5K	1.6M	1.3M	1.1M	1.0M	901.4K
Total Current Liabilities	1.4M	3.8M	3.3M	4.2M	3.8M	2.0M
Total Stockholder Equity	21.5M	16.4M	11.2M	1.8M	1.6M	1.6M
Property Plant And Equipment Net	637.7K	953.3K	599.2K	264.5K	238.0K	226.1K
Net Debt	(20.7M)	(11.1M)	(7.3M)	(145.4K)	(130.9K)	(137.4K)
Retained Earnings	(143.1M)	(150.2M)	(156.7M)	(166.4M)	(149.7M)	(142.3M)
Accounts Payable	269.7K	1.2M	838.0K	1.5M	1.3M	789.6K
Cash	20.9M	11.7M	7.9M	1.0M	1.2M	1.1M
Non Current Assets Total	735.6K	6.1M	4.2M	2.5M	2.2M	2.1M
Non Currrent Assets Other	(9.5M)	(6.1M)	(4.2M)	81.7K	73.5K	77.2K
Cash And Short Term Investments	20.9M	11.7M	7.9M	1.0M	1.2M	1.1M
Net Receivables	1.1M	2.4M	191.9K	2.1M	2.4M	2.6M
Common Stock Shares Outstanding	85.4M	92.2M	101.4M	138.4M	124.5M	118.3M
Liabilities And Stockholders Equity	23.0M	20.8M	14.9M	6.2M	5.6M	5.3M
Inventory	76.9K	398.2K	325.9K	206.5K	185.8K	176.5K
Other Stockholder Equity	1.2M	(10.5M)	(4.9M)	(4.6M)	(4.2M)	(4.0M)
Total Liab	1.4M	4.4M	3.7M	4.4M	3.9M	2.3M
Property Plant And Equipment Gross	1.3M	1.9M	1.8M	1.5M	1.4M	946.1K
Total Current Assets	22.2M	14.7M	10.5M	3.7M	4.2M	4.0M
Common Stock	153.6M	155.1M	161.3M	163.8M	188.4M	99.3M
Property Plant Equipment	440.2K	637.7K	953.3K	599.2K	539.3K	876.6K
Short Long Term Debt Total	204.0K	652.5K	532.9K	875.2K	787.7K	509.7K
Other Current Assets	182.6K	18.2K	2.1M	341.7K	393.0K	461.4K
Short Term Debt	179.6K	264.1K	303.6K	852.3K	980.1K	1.0M
Short Term Investments	1.9K	13.3K	17.4K	18.8K	16.9K	16.1K
Non Current Liabilities Total	33.3K	558.9K	381.6K	160.6K	144.6K	137.4K
Accumulated Other Comprehensive Income	11.0M	11.5M	6.5M	4.4M	5.0M	4.3M
Current Deferred Revenue	635.0	814.2K	849.2K	741.6K	852.9K	895.5K
Other Liab	979.2K	8.9K	170.5K	152.3K	175.2K	133.1K
Net Tangible Assets	13.0M	21.5M	11.3M	7.5M	8.7M	11.1M
Long Term Debt Total	240.9K	24.4K	388.4K	229.3K	263.7K	138.8K
Net Invested Capital	21.5M	16.4M	11.2M	2.5M	2.8M	2.7M
Net Working Capital	20.8M	10.9M	7.2M	(500.1K)	(450.1K)	(427.6K)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Genetic Stock Analysis

When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC